Carboxylesterase Detection and Activity Profiling

High-Sensitivity Carboxylesterase Detection and Activity Profiling for Food Safety, Drug Metabolism, and Environmental Toxicology

Carboxylesterases (EC 3.1.1.1) are a ubiquitous and highly diverse family of serine hydrolases that catalyse the hydrolysis of ester- and amide-containing compounds, including endogenous esters, xenobiotics, prodrugs, and environmental pollutants. They play critical roles in the detoxification of organophosphorus pesticides, the metabolism of pharmaceuticals (e.g., the activation of the antiplatelet agent clopidogrel and the prodrug capecitabine), and the regulation of lipid homeostasis. Dysregulation of carboxylesterase activity is implicated in metabolic syndrome, drug resistance, and hepatotoxicity. Furthermore, these enzymes are widely used as biocatalysts in the synthesis of fine chemicals, pharmaceuticals, and chiral intermediates. The accurate, sensitive, and comprehensive detection and characterisation of carboxylesterases—covering hydrolytic activity, substrate specificity, kinetic parameters, protein abundance, isoform discrimination, and inhibitor sensitivity—is essential for food quality control, pesticide residue monitoring, drug metabolism studies, and the development of enzyme-based therapeutic and industrial products. Our specialised detection platform provides a fully validated suite of biochemical, chromatographic, and mass spectrometric assays tailored to carboxylesterases from human, animal, plant, microbial, and recombinant sources, delivering the high-precision, regulatory-ready data required for research, development, and compliance.

Scientific, Clinical, and Industrial Rationale for Carboxylesterase Analysis

Clients seeking carboxylesterase detection services are motivated by a range of critical objectives across multiple sectors. In food safety and quality control, the primary need is to quantify carboxylesterase activity as a marker of insecticide exposure or as a quality index of freshness in fruits and vegetables, ensuring consumer safety and regulatory compliance (e.g., EU and US EPA pesticide MRL regulations). In drug development and pharmacology, measuring carboxylesterase activity in liver microsomes or plasma is essential for evaluating the hydrolysis of ester prodrugs, predicting drug-drug interactions, and assessing the risk of inter-individual variability in drug metabolism due to polymorphism. In clinical diagnostics and biomarker discovery, altered carboxylesterase expression or activity in plasma and tissues has been linked to cancer, obesity, and liver disease, making it a potential biomarker. In environmental toxicology, the inhibition of carboxylesterases is a sensitive indicator of exposure to organophosphorus and carbamate pesticides in wildlife (e.g., birds, fish) and human biomonitoring studies. In biocatalysis and industrial biotechnology, detailed kinetic parameters and substrate specificity profiles are required for selecting robust enzymes for the synthesis of pharmaceuticals, flavours, and polymers. In quality control of enzyme preparations, verifying the specific activity, purity, and stability of recombinant carboxylesterase standards is essential for diagnostic kit production and reference material use. In regulatory submissions, comprehensive data on enzyme activity, selectivity, and stability are required for the approval of novel biocatalysts, prodrugs, and diagnostic devices. Our service is architected to address these diverse needs with a flexible, ISO 17025-accredited analytical framework that adapts to the specific enzyme source, sample matrix, and client's research, industrial, or regulatory context.

Integrated Analytical Platform for Holistic Carboxylesterase Characterisation

Our analytical platform comprises four interconnected modules that collectively deliver a comprehensive evaluation of carboxylesterase quality, activity, and specificity. The Activity Quantification Module employs a range of validated assays using either chromogenic or fluorogenic substrates (such as p-nitrophenyl acetate/butyrate, 4-methylumbelliferyl acetate/butyrate, or α-naphthyl acetate), or by the direct measurement of product formation via UHPLC-MS/MS. We determine the specific activity (U/mg protein) with precision within ±2% RSD and a limit of detection (LOD) as low as 0.001 U/mL. For detailed kinetic characterisation, we calculate Michaelis-Menten parameters (K_m, V_max, k_cat) for a panel of ester substrates (including butyrate, caprylate, and phenylacetate derivatives) and inhibition constants (IC₅₀, K_i) for organophosphates, carbamates, and other test compounds, with 95% confidence intervals typically within ±5%. The Substrate Specificity and Isoform Module profiles the enzyme's activity against a custom panel of up to 15 ester substrates to generate a specificity fingerprint that can distinguish between the major human isoforms (hCE1, hCE2) and other mammalian or microbial isozymes. For absolute protein quantitation and isoform discrimination, we use ELISA with isoform-specific antibodies (e.g., anti-hCE1, anti-hCE2), providing LOQs of 0.05 ng/mg of total protein and inter-assay precision < 5%, and LC-MS/MS-based targeted proteomics (PRM) with stable isotope-labelled peptide standards, achieving LOQs in the low fmol/mg range and enabling the simultaneous quantitation of multiple carboxylesterase isoforms in a single run. The Purity and Structural Module uses SDS-PAGE with silver or Coomassie staining, size-exclusion chromatography (SEC-HPLC), and capillary electrophoresis (CE) to assess purity, detect aggregates, and confirm the presence of active glycosylated forms. For identification, we perform intact mass analysis by ESI-TOF MS and LC-MS/MS peptide mass fingerprinting to confirm the enzyme's identity and to detect post-translational modifications (e.g., glycosylation) that are known to affect activity and stability. The Inhibitor, Stability, and Formulation Module evaluates the enzyme's sensitivity to common inhibitors (e.g., organophosphates, carbamates, and specific serine hydrolase inhibitors), its stability under various storage conditions (temperature, freeze-thaw, pH), and its resistance to process-relevant conditions (e.g., detergents, organic solvents). Using Arrhenius modelling and deactivation kinetics, we predict shelf-life and identify critical degradation pathways (e.g., deamidation, oxidation, proteolysis). All modules are validated with reference carboxylesterase standards (commercial or in-house) and include rigorous quality controls (system suitability, blank subtraction, and replicate analyses).

Unmatched Analytical Sensitivity, Specificity, and Mechanistic Depth

Our platform consistently delivers performance that surpasses typical industry and academic standards. In activity assays, we achieve signal-to-noise ratios > 300:1 at the LOD, with linearity over four orders of magnitude and Z’-factors consistently > 0.8, making our assays highly robust for high-throughput screening of inhibitors or enzyme variants. Our kinetic fitting software uses global non-linear regression to provide precise estimates of K_m and V_max, with residual errors < 2%. For protein quantitation by PRM, our chromatographic gradient resolves isoform-specific peptides with retention time reproducibility < 0.5% RSD and peak area precision < 3%. In inhibitor studies, we perform full dose-response curves with at least 8 concentrations in triplicate, and we provide Dixon plots and Cornish-Bowden analyses to determine the mechanism of inhibition (competitive, uncompetitive, or mixed). Additionally, we offer isothermal titration calorimetry (ITC) to measure the binding thermodynamics of inhibitors, providing ΔH, ΔS, and binding stoichiometry with precision within ±2%. For clients requiring detailed structural insight, we perform hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map ligand-binding sites and conformational changes. This multi-dimensional data set enables our clients to not only quantify enzyme activity but also to understand the molecular basis of substrate recognition, catalytic mechanism, and inhibition, facilitating the rational design of more selective inhibitors or engineered enzymes with enhanced substrate specificity.

Distinctive Advantages of Our Carboxylesterase Detection Service

Our service provides several unique benefits that directly address client challenges. First, we have developed matrix-specific sample preparation protocols for a wide variety of carboxylesterase sources—including liver microsomes, plasma, tissue homogenates, cell lysates, food extracts, environmental samples, and purified recombinant proteins—that effectively preserve enzyme activity and protein integrity, achieving recoveries > 95% for all tested matrices. Second, we maintain a comprehensive reference library of carboxylesterase isoforms (including hCE1, hCE2, CES1, CES2) and their known substrate and inhibitor profiles, enabling rapid method setup and confident benchmarking. Third, we offer a rapid screening service using a microplate-based fluorescence assay that provides semi-quantitative activity data within 1 hour of sample receipt—ideal for large-scale environmental monitoring, clinical screening, or early-stage inhibitor discovery. Fourth, our customised kinetic and inhibition studies can be tailored to simulate physiological or environmental conditions, including the presence of plasma proteins, detergents, and relevant cofactors. Fifth, we provide integrated data interpretation that links enzyme activity, isoform abundance, and inhibition profiles to biological, clinical, or industrial outcomes (e.g., prodrug activation efficiency, pesticide toxicity, shelf-life), enabling clients to make informed decisions on candidate selection and application. Sixth, all our methods comply with ICH M10, FDA, and EPA guidelines on bioanalytical method validation, and we supply full validation dossiers (specificity, linearity, accuracy, precision, LOD, LOQ, robustness) along with detailed SOPs, ensuring that our data are readily accepted by regulatory authorities. Our team of enzymologists, toxicologists, and analytical chemists provides consultative interpretation, helping clients to design follow-up experiments, predict in vivo outcomes, and support regulatory submissions.

Advanced Data Integration, Predictive Modeling, and Reporting

Our reporting transforms analytical data into strategic decision-making knowledge. We deliver a comprehensive final report that includes: (i) an executive dashboard with key metrics (specific activity, K_m, IC₅₀, K_i, isoform ratio, purity, and stability half-life) presented as concise scorecards; (ii) a detailed analytical section containing raw data, calibration curves, kinetic fits, and chromatograms; (iii) a statistical comparison of samples against reference standards or historical data, with p-values and confidence intervals; and (iv) an interpretive narrative that contextualises the results—for example, explaining how a high K_m indicates low substrate affinity, or how a low IC₅₀ for a pesticide suggests high toxicity risk. For clients with multiple compounds, samples, or time-points, we provide multivariate analysis (PCA, PLS-DA) to identify the most influential parameters and to guide selection. We also offer predictive models that estimate in vivo drug metabolism or environmental degradation rates based on in vitro enzyme data, using our internally developed pharmacokinetic and ecotoxicological modelling tools. All raw data files (e.g., .xlsx, .raw, .cdf) are supplied to ensure full transparency and re-analysis capability.

Broad Applications Across Food Safety, Drug Discovery, and Environmental Monitoring

The versatility of our carboxylesterase detection service spans a wide range of sectors. In food and agricultural safety, we quantify carboxylesterase activity to monitor pesticide contamination and assess the freshness and quality of produce. In pharmaceutical and biotech R&D, our assays are critical for evaluating prodrug metabolism, predicting drug-drug interactions, and optimising lead compounds. In clinical diagnostics, we measure carboxylesterase expression in patient samples to support biomarker studies and treatment decisions. In environmental monitoring, we assess carboxylesterase inhibition in wildlife and aquatic species as a sensitive indicator of organophosphate exposure. In industrial biotechnology, we characterise microbial carboxylesterases for the synthesis of chiral pharmaceuticals and fine chemicals. In academic research, our comprehensive profiling supports publication-quality studies on enzyme regulation, evolution, and mechanism. In contract research organisations (CROs), our services provide robust data to support regulatory submissions. Our ability to tailor the analytical package to the specific enzyme source, substrate class, and regulatory framework ensures that we serve a diverse global clientele with scientific rigour and practical relevance.

Commitment to Innovation, Quality, and Client Partnership

We are dedicated to advancing carboxylesterase analytics through continuous technological improvement. Our current R&D includes the development of microfluidic-based single-molecule activity assays for ultra-sensitive detection in precious clinical samples, and the application of machine learning algorithms to predict substrate specificity from primary sequence data. We actively participate in inter-laboratory proficiency testing for enzyme activity and protein analysis, and we contribute to the development of reference standards for carboxylesterases. Our quality management system is ISO 9001 and ISO 17025 certified, and we follow GLP for all regulatory studies. We offer flexible engagement models—from single-sample analysis to multi-year collaborative projects—with dedicated project managers, volume discounts, and priority handling for time-sensitive samples. Our global logistics provide specialised shipping kits (with stabilising buffers and temperature control) to preserve enzyme activity during transit. Turnaround times range from 1 business day for rapid screening to 12 business days for comprehensive kinetic, proteomic, and inhibition profiling. We maintain open communication, providing preliminary results upon request and final reports with expert commentary. Our success is measured by the confidence our clients have in their data and their ability to advance research, development, and regulatory compliance. We invite you to partner with us to unlock the full potential of your carboxylesterase research.

In summary, our carboxylesterase detection service delivers a comprehensive, precise, and application-oriented analytical solution that integrates activity quantification, substrate specificity profiling, inhibitor screening, protein quantitation, and stability evaluation. By combining advanced instrumentation with deep expertise in esterase enzymology and toxicology, we empower our clients to ensure food safety, optimise drug development, and protect the environment. We look forward to supporting your carboxylesterase analysis needs with our state-of-the-art analytical platform.